Indivior Pharmaceuticals annual net debt
2021
2022
2023
2024
2025
Indivior Pharmaceuticals Net Debt Growth & History (INDV)
Indivior Pharmaceuticals's net debt was $156.0M for fiscal 2025.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $156.0M | $100.0M | +178.57% |
| 2024 | 2024-12-31 | $56.0M | −$25.0M | −30.86% |
| 2023 | 2023-12-31 | $81.0M | $494.0M | — |
| 2022 | 2022-12-31 | −$413.0M | $329.0M | — |
| 2021 | 2021-12-31 | −$742.0M | — | — |
Indivior Pharmaceuticals quarterly net debt
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $287.0M | $431.0M | — |
| Q1 2026 | 2026-03-31 | $334.0M | $336.0M | — |
| Q4 2025 | 2025-12-31 | $156.0M | $100.0M | +178.57% |
| Q3 2025 | 2025-09-30 | −$89.0M | — | — |
| Q2 2025 | 2025-06-30 | −$144.0M | — | — |
| Q1 2025 | 2025-03-31 | −$2.0M | — | — |
| Q4 2024 | 2024-12-31 | $56.0M | −$25.0M | −30.86% |
| Q4 2023 | 2023-12-31 | $81.0M | $494.0M | — |
| Q4 2022 | 2022-12-31 | −$413.0M | — | — |
Indivior Pharmaceuticals net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Indivior Pharmaceuticals's net debt increased from −$742.0M to $156.0M, a change of $898.0M. The latest reported quarter, Q2 2026, shows $287.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indivior Pharmaceuticals source filings ↗